07/03/2025
3:30 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
6:48 PM | BridgeBio Pharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
6:49 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SCHEDULE 13D/A | |
07/01/2025
3:31 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025
3:31 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2025
4:54 PM | BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
4:46 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4/A | |
06/30/2025
4:49 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4/A | |
06/30/2025
4:51 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
4:08 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:13 PM | BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for BBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BridgeBio Pharma and its competitors with MarketBeat's FREE daily newsletter. |
06/26/2025
3:14 PM | BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2025
3:16 PM | BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2025
3:19 PM | BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2025
6:06 PM | BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
6:06 PM | BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
6:07 PM | AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
6:07 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
6:10 PM | BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
6:12 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
6:13 PM | BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:56 PM | BridgeBio Pharma (Issuer)
Hassan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:56 PM | BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:57 PM | BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:54 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:55 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
5:55 PM | BridgeBio Pharma (Issuer)
Dachille Douglas A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
4:59 PM | BridgeBio Pharma (Subject)
MCCORMICK FRANK (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:29 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
4:00 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
5:06 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:05 PM | Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:07 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
3:25 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2025
4:24 PM | BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:52 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
| Form SCHEDULE 13D/A | |
05/12/2025
8:46 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2025
5:00 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
3:40 PM | BridgeBio Pharma (Filer)
| Form DEFA14A | |
05/06/2025
3:42 PM | BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2025
3:45 PM | Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Trump Dump is starting; Get out of stocks now? (Ad) The first 365 days of the Trump presidency…
Will be the best time to get rich in American history. If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a |
04/30/2025
5:01 AM | BridgeBio Pharma (Filer)
| Form DEF 14A | |
04/30/2025
5:02 AM | BridgeBio Pharma (Filer)
| Form ARS | |
04/16/2025
4:39 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
4:06 PM | BridgeBio Pharma (Filer)
| Form PRE 14A | |
04/14/2025
3:21 PM | BridgeBio Pharma (Subject)
Ellis Andrea (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2025
4:11 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
3:48 PM | BridgeBio Pharma (Subject)
Ellis Andrea (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025
3:54 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:32 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:09 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:03 PM | Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:28 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SCHEDULE 13D/A | |
03/10/2025
3:43 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:09 PM | BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:15 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/06/2025
3:06 PM | BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
8:09 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
7:22 PM | Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/27/2025
4:36 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
3:35 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
7:48 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:50 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:51 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:31 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:31 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
4:23 PM | BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
6:18 PM | BridgeBio Pharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
6:18 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
6:18 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SCHEDULE 13D/A | |
01/30/2025
5:29 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
5:31 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
3:18 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
3:18 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
3:53 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:43 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4/A | |
12/31/2024
4:52 PM | BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
6:18 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
6:05 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
8:16 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:57 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
7:00 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:06 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:13 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:15 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
3:24 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
10:44 AM | BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
I warned you about Nvidia… now look what’s happening (Ad) Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open.
That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits. Watch how Tim Sykes trades AI headlines for real gains |
11/06/2024
4:04 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
09/17/2024
5:44 PM | BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
5:41 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
| Form SC 13D/A | |
09/13/2024
4:04 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:16 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
7:42 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
08/20/2024
5:24 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
